Share this with FacebookShare this with TwitterShare this with LinkedInEmail this pagePrint this page
ABC News: FDA approves drug for heart failure that may keep patients out of the hospital during the COVID-19 pandemic
AstraZeneca's diabetes drug, Farxiga, has become the first in its class to receive FDA approval as a treatment for heart failure.
ABC News talked to Dr. Mikhail Kosiborod, cardiologist at Saint Luke's Mid America Heart Institute and vice president of research at Saint Luke's, who investigated the drug before its approval.
AstraZeneca is also studying whether the drug may benefit certain patients with COVID-19—some who suffer from mysterious problems like blood clots and heart damage.
Read the full ABC News article: FDA approves drug for heart failure that may keep patients out of the hospital during the COVID-19 pandemic